Please enable JavaScript.
Coggle requires JavaScript to display documents.
Crohn's Disease, When pt's disease is not controlled with low-dose…
Crohn's Disease
Pathophysiology
Presentation
Subjective
-
-
-
-
-
-
-
Sudden, violent diarrhea occurring nocturnally
-
-
-
-
Intermittent areas of diseased bowel are sharply demarcated from adjacent normal bowel (called skip areas)
Epithelioid (sarcoid-like) granulomas are detected in bowel wall or lymph nodes in 25‒50% of cases (pathognomonic).
Health History
-
-
Etiology
NIH Theory: An autoimmune reaction. Experts think bacteria in your digestive tract can mistakenly trigger your immune system. This immune system response causes inflammation, leading to symptoms of Crohn's disease
-
-
Crohn's disease begins with crypt inflammation and abscesses, which progress to tiny focal aphthoid ulcers. These mucosal lesions may develop into deep longitudinal and transverse ulcers with intervening mucosal edema, creating a characteristic cobblestoned appearance to the bowel.
Plan of Care
Pharmacotherapy There is no curative therapy-Treatment is targeted to suppress inflammatory process & provide symptomatic relief.
Non-pharmacotherapy
-
Diet
-
-
In-between attacks, pt's can eat whatever they can tolerate
Parental nutrition or oral supplementation for malnutrition pts can sometimes be indicated in severe cases.
-
-
-
Immunomodulators reduce immune system activity, decreasing inflammation in the GI tract.
-
-
-
-
-
-
-
Biologic therapies (MOD to Severe Cases): target proteins made by the immune system. Neutralizing these proteins decreases inflammation in the intestines.
Anti-TNF-alpha therapies: adalimumab, certolizumab, and infliximab
-
-
-
FIRST LINE THERAPY: Steroids for rapid ease of s/s with prompt referral to Gastroenterology for further symptom management/diagnosis and management.
-
Proper inflammatory management can reduces the risk of penetrating complications (fistulas/abbesses)
-
Patient Education
-
Pts are at higher risk for osteopenia and osteoporosis. Educate on importance of increased weight bearing exercise for bone protection.
-
This is a life long condition that is not curable, but with proper treatment, support and recourses we can decrease amount of flares pt's experience.
Ask to bring families in during education session, encourage families to be supportive and s/s of decline and when to see help
-
Cultural
Our cultural background, where we grow up, our ethnicity, religion, and diet culture may all play a role in our relationship with food.
Research suggests that up to three quarters of patients with IBD have a decreased satisfaction in eating since their diagnosis
-
-
Epidemiology
Inflammatory bowel disease affects people of all ages but usually begins before age 30, with peak incidence from 14 to 24. IBD may have a second smaller peak between ages 50 and 70; however, this later peak may include some cases of ischemic colitis.
-
IBD affects Northern European and Anglo-Saxon origin and is 2 to 4 times more common among Ashkenazi Jews than non-Jewish White people from the same geographic location.
-
-
Inflammatory bowel disease (IBD), which includes Crohn disease and ulcerative colitis, is a relapsing and remitting condition characterized by chronic inflammation at various sites in the gastrointestinal tract, which results in diarrhea and abdominal pain.
Prevalence: 100 to 300 per 100,000 people.
Information Technology
-
LyfeMD is a virtual solution designed by gastroenterologists and registered dieticians to put the power of diet, nutrition, and lifestyle therapies into the hands of patients
-
-
Trellus Health is a digital health company founded by experts with over 25 years of treating and healing both the physical and emotional impact of IBD
-